IRIS-BioFreedom Cohort in the IRIS-DES Registry

BIOFREEDOM™ FAMILY stent means that Biofreedom stent, Biofreedom Ultra and the other stents with names starting with Biofreedom.

• BIOFREEDOM™ FAMILY stent (Device): Percutaneous coronary intervention with BIOFREEDOM™ FAMILY stent

Primary outcomes

• Composite event rate of death, non-fatal myocardial infarction (MI), or Target- Vessel Revascularization (TVR) [1 year]

Secondary outcomes

• All cause death [5 year]
• Cardiac death [5 year]
• Myocardial Infarction [5 year]
• Composite event rate of death or myocardial infarction (MI) [5 year]
• Composite event rate of cardiac death or myocardial infarction (MI) [5 year]
• Target- Vessel Revascularization [5 year]
• Target- Lesion Revascularization [5 year]
• Stent thrombosis [5 year]
• Stroke [5 year]
• Procedural Success rate [5 day]: defined as achievement of a final diameter stenosis of <30% by visual estimation, without the occurrence of death, Q-wave MI, or urgent revascularization during the index hospitalization.

Sex: All, ages: 19 Years to any

Inclusion Criteria:

* Age 19 and more
* Patient with BIOFREEDOM™ FAMILY stent
* Written consent

Exclusion Criteria:

* Intervention with BIOFREEDOM™ FAMILY stent and other drug eluting stent at the same time
* Life-expectancy less than 1 year
* Cardiac shock